Accumulation of intermediate metabolites of the tricarboxylic acid (TCA) cycle in tumor cells can cause epithelial-to-mesenchymal transition (EMT), although the exact mechanisms remain elusive. Recent studies show that the oncometabolite fumarate, which accumulates in fumarate hydratase-deficient renal cancers, confers tumor aggressiveness by causing epigenetic changes in the antimetastatic miRNA cluster mir-200ba429. This may have important implications for the use of fumarates in the clinic. Copyright © 2016 Elsevier Ltd. All rights reserved.
Gwenny M Fuhler, Hester Eppinga, Maikel P Peppelenbosch. Fumarates and Cancer. Trends in molecular medicine. 2017 Jan;23(1):3-5
PMID: 27986420
View Full Text